Enhanced pelvic responses to stressors in female CRF-overexpressing mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 4, 2007, Pages

  Million, M ^a   Wang, L ^a   Stenzel Poore, M P ^b   Coste, S C ^b   Yuan, P Q ^a   Lamy, C ^a   Rivier, J ^c   Buffington, T ^d   Tache Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Astressin B; Chronic stress; Colon; Locomotor activity; Mouse urocortin 2; Urine

Indexed keywords

ASTRESSIN; ASTRESSIN B; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HORMONE RESPONSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; COLON; CORTICOTROPIN-RELEASING HORMONE; DEFECATION; ENVIRONMENT; FEMALE; HANDLING (PSYCHOLOGY); INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PELVIS; PEPTIDE FRAGMENTS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; TIME FACTORS; URINATION;

EID: 34147109702     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00626.2006     Document Type: Article

References (78)

1. Almy TP, Kern F Jr, Tulin M. Alterations in colonic function in man under stress. II. Experimental production of sigmoid spasm in healthy persons. Gastroenterology 12: 425-436, 1949.
2. Bale TL. Sensitivity to stress: dysregulation of CRF pathways and disease development. Horm Behav 48: 1-10, 2005.
3. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24: 410-414, 2000.
4. Bale TL, Vale WW. CRF and CRF receptor: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-557, 2004.
5. Barrachina MD, Martinez V, Wang L, Wei JY, Taché Y. Synergistic interaction between leptin and cholecystokinin to reduced short-term food intake in lean mice. Proc Natl Acad Sci USA 94: 10455-10460, 1997.
6. Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol 172: 1242-1248, 2004.
7. Castagliuolo I, Lamont JT, Qiu B, Fleming SM, Bhaskar KR, Nikulasson ST, Kornetsky C, Pothoulakis C. Acute stress causes mucin release from rat colon: role of corticotropin-releasing factor and mast cells. Am J Physiol Gastrointest Liver Physiol 271: G884-G892, 1996.
8. Chatzaki E, Crowe PD, Wang L, Million M, Taché Y, Grigoriadis D. CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J Neurochem 90: 309-316, 2004.
9. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 52: 597-617, 1996.
10. Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, Brown SO, Gao SY, Calhoun EA. Prevalence of interstitial cystitis symptoms in a managed care population. J Urol 174: 576-580, 2005.
11. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin- releasing hormone receptor-2. Nat Genet 24: 403-409, 2000.
12. Coste SC, Murray SE, Stenzel-Poore MP. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 22: 733-741, 2001.
13. De Groat WC. Integrative control of the lower urinary tract: Preclinical perspective. Br J Pharmacol 147: S25-S40, 2006.
14. Desjardins C, Maruniak JA, Bronson FH. Social rank in house mice: differentiation revealed by ultraviolet visualization of urinary marking patterns. Science 182: 939-941, 1973.
15. Dirks A, Groenink L, Bouwknecht JA, Hijzen TH, Van Der GJ, Ronken E, Verbeek JS, Veening JG, Dederen PJ, Korosi A, Schoolderman LF, Roubos EW, Olivier B. Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. Eur J Neurosci 16: 1751-1760, 2002.
16. Groenink L, Dirks A, Verdouw PM, Schipholt M, Veening JG, Van Der GJ, Olivier B. HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol Psychiatry 51: 875-881, 2002.
17. Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 97: 6079-6084, 2000.
18. Haeger P, Andres ME, Forray MI, Daza C, Araneda S, Gysling K. Estrogen receptors alpha and beta differentially regulate the transcriptional activity of the urocortin gene. J Neurosci 26: 4908-4916, 2006.
19. Halpert A, Drossman D. Biopsychosocial issues in irritable bowel syndrome. J Clin Gastroenterol 39: 665-669, 2005.
20. Harada S, Imaki T, Naruse M, Chikada N, Nakajima K, Demura H. Urocortin mRNA is expressed in the enteric nervous system of the rat. Neurosci Lett 267: 125-128, 1999.
21. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev 55: 21-26, 2003.
22. Heinrichs SC, Min H, Tamraz S, Carmouche M, Boehme SA, Vale WW. Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology 22: 215-224, 1997.
23. Heinrichs SC, Stenzel-Poore MP, Gold LH, Battenberg E, Bloom FE, Koob GF, Vale WW, Pich EM. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience 74: 303-311, 1996.
24. Heitkemper M, Jarrett M, Bond EF, Chang L. Impact of sex and gender on irritable bowel syndrome. Biol Res Nurs 5: 56-65, 2003.
25. Henry B, Vale W, Markou A. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. J Neurosci 26: 9142-9152, 2006.
26. Hotta M, Shibasaki T, Yamauchi N, Ohno H, Benoit R, Ling N, Demura H. The effects of chronic central administration of corticotropin-releasing factor on food intake, body weight, and hypothalamic-pituitary-adrenocortical hormones. Life Sci 48: 1483-1491, 1991.
27. Kastin AJ, Akerstrom V. Differential interactions of urocortin/corticotropin-releasing hormone peptides with the blood-brain barrier. Neuroendocrinology 75: 367-374, 2002.
28. Kiddoo DA, Valentino RJ, Zderic S, Ganesh A, Leiser SC, Hale L, Grigoriadis DE. Impact of state of arousal and stress neuropeptides on urodynamic function in freely moving rats. Am J Physiol Regul Integr Comp Physiol 290: R1697-R1706, 2006.
29. Klausner AP, Steers WD. Corticotropin releasing factor: a mediator of emotional influences on bladder function. J Urol 172: 2570-2573, 2004.
30. Klausner AP, Streng T, Na YG, Raju J, Batts TW, Tuttle JB, Andersson KE, Steers WD. The role of corticotropin releasing factor and its antagonist, astressin, on micturition in the rat. Auton Neurosci 123: 26-35, 2005.
31. Kozicz T, Arimura A. Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase. Peptides 23: 515-521, 2002.
32. Laberge J, Malley SE, Zvarova K, Vizzard MA. Expression of corticotropin-releasing factor (CRF) and CRF receptors in micturition pathways after cyclophosphamide (CYP)-induced cystitis. Am J Physiol Regul Integr Comp Physiol 291: R692-R703, 2006.
33. Linthorst AC, Flachskamm C, Hopkins SJ, Hoadley ME, Labeur MS, Holsboer F, Reul JM. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J Neurosci 17: 4448-4460, 1997.
34. Liu S, Gao X, Gao N, Wang X, Fang X, Hu HZ, Wang GD, Xia Y, Wood JD. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system. J Comp Neurol 481: 284-298, 2005.
35. Lund TD, Rovis T, Chung WC, Handa RJ. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 146: 797-807, 2005.
36. Maillot C, Million M, Wei JY, Gauthier A, Taché Y. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology 119: 1569-1579, 2000.
37. 1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des 12: 1-18, 2006.
38. Martinez V, Wang L, Rivier J, Grigoriadis D, Taché Y. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J Physiol 556.1: 221-234, 2004.
39. Martinez V, Wang L, Rivier JE, Vale W, Taché Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 301: 611-617, 2002.
40. Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and the gastrointestinal tract. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 280: G519-G524, 2001.
41. 1 receptor in conscious rats. Am J Physiol Gastrointest Liver Physiol 282: G857-G865, 2002.
42. Million M, Maillot C, Adelson DW, Nozu T, Gauthier A, Rivier C, Chrousos GP, Bayati A, Mattsson H, Taché Y. Peripheral injection of sauvagine prevents repeated colorectal distention-induced visceral pain in female rats. Peptides 26: 1188-1195, 2005.
43. 2-mediated action on gastric transit in rats. Am J Physiol Gastrointest Liver Physiol 282: G34-G40, 2002.
44. Million M, Wang L, Wang Y, Adelson DW, Yuan PQ, Maillot C, Coutinho SV, McRoberts JA, Bayati A, Mattsson H, Wu VS, Wei JY, Rivier J, Vale W, Mayer EA, Taché Y. CRF2 receptor activation prevents colorectal distension-induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut 55: 172-181, 2006.
45. Monga AK, Marrero JM, Stanton SL, Lemieux MC, Maxwell JD. Is there an irritable bladder in the irritable bowel syndrome? Br J Obstet Gynaecol 104: 1409-1412, 1997.
46. Murray SE, Rosenzweig HL, Johnson M, Huising MO, Sawicki K, Stenzel-Poore MP. Overproduction of corticotropin-releasing hormone blocks germinal center formation: role of corticosterone and impaired follicular dendritic cell networks. J Neuroimmunol 156: 31-41, 2004.
47. Nijsen M, Ongenae N, Meulemans A, Coulie B. Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain. Neurogastroenterol Motil 17: 423-432, 2005.
48. Pavcovich LA, Valentino RJ. Central regulation of micturition in the rat the corticotropin-releasing hormone from Barrington's nucleus. Neurosci Lett 196: 185-188, 1995.
49. Richardson HN, Zorrilla EP, Mandyam CD, Rivier CL. Exposure to repetitive versus varied stress during prenatal development generates two distinct anxiogenic and neuroendocrine profiles in adulthood. Endocrinology 147: 2506-2517, 2006.
50. Rivier CL, Grigoriadis DE, Rivier JE. Role of corticotropin- releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology 144: 2396-2403, 2003.
51. Rivier J, Gulyas J, Corrigan A, Martinez V, Craig AG, Taché Y, Vale W, Rivier C. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat. J Med Chem 41: 5012-5019, 1998.
52. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Taché Y, Vale W. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45: 4737-4747, 2002.
53. Rivier J, Rivier C, Vale W. Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science 224: 889-891, 1984.
54. Rivier JE, Kirby DA, Lahrichi SL, Corrigan A, Vale WW, Rivier CL. Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat. J Med Chem 42: 3175-3182, 1999.
55. Rothrock NE, Lutgendorf SK, Kreder KJ, Ratliff T, Zimmerman B. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology 57: 422-427, 2001.
56. Rouzade-Dominguez ML, Pernar L, Beck S, Valentino RJ. Convergent responses of Barrington's nucleus neurons to pelvic visceral stimuli in the rat: a juxtacellular labelling study. Eur J Neurosci 18: 3325-3334, 2003.
57. Sasaki M. Role of Barrington's nucleus in micturition. J Comp Neurol 493: 21-26, 2005.
58. Soderholm JD, Perdue MH II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 280: G7-G13, 2001.
59. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130: 3378-3386, 1992.
60. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 14: 2579-2584, 1994.
61. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, Stenzel-Poore MP. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9: 637-645, 1995.
62. Straub LR, Ripley HS, Wolf S. Disturbances of bladder function associated with emotional states. JAMA 141: 1139-1143, 1949.
63. Sudre EC, de Barros MR, Sudre GN, Schenberg LC. Thresholds of electrically induced defence reaction of the rat: short- and long-term adaptation mechanisms. Behav Brain Res 58: 141-154, 1993.
64. Sutton RE, Koob GF, LeMoal M, Rivier J, Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature 297: 331-333, 1982.
65. Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract. III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 280: G173-G177, 2001.
66. Taché Y, Million M. Central corticotropin-releasing factor and the hypothalamic-pituitary-adrenal axis in gastrointestinal physiology. In: Physiology of the Gastrointestinal Tract, edited by Johnson LR and Wood J. New York: Academic, 2006, p. 791-816.
67. 1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol 141: 1321-1330, 2004.
68. Taché Y, Perdue MH. Role of peripheral CRF signaling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 16, Suppl 1: 1-6, 2004.
69. Torpy DJ, Papanicolaou DA, Chrousos GP. Sexual dimorphism of the human stress response may be due to estradiol-mediated stimulation of hypothalamic corticotropin-releasing hormone synthesis. J Clin Endocrinol Metab 82: 982, 1997.
70. Tovote P, Meyer M, Ronnenberg A, Ogren SO, Spiess J, Stiedl O. Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing mice. Neuroscience 134: 1113-1122, 2005.
71. Valentino RJ, Miselis RR, Pavcovich LA. Pontine regulation of pelvic viscera: pharmacological target for pelvic visceral dysfunctions. Trends Pharmacol Sci 20: 253-260, 1999.
72. Van Gaalen MM, Stenzel-Poore MP, Holsboer F, Steckler T. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci 15: 2007-2015, 2002.
73. Vincent SR, Satoh K. Corticotropin-releasing factor (CRF) immunoreactivity in the dorsolateral pontine tegmentum: further studies on the micturition reflex system. Brain Res 308: 387-391, 1984.
74. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le Fur G, Caput D, Ferrara P. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335: 1-5, 1993.
75. Wagner M, Perry RP. Characterization of the multigene family encoding the mouse S16 ribosomal protein: strategy for distinguishing an expressed gene from its processed pseudogene counterparts by an analysis of total genomic DNA. Mol Cell Biol 5: 3560-3576, 1985.
76. Williams CL, Burks TF. Stress, opioids, and gastrointestinal transit. In: Hans Selye Symposia on Neuroendocrinology and Stress: Neuropeptides and Stress, edited by Taché Y, Morley J, and Brown MR. New York: Springer-Verlag, 1989, p. 175-187.
77. Williams CL, Peterson JM, Villar RG, Burks TF. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol Gastrointest Liver Physiol 253: G582-G586, 1987.
78. Wu EQ, Birnbaum H, Kang YJ, Parece A, Mallett D, Taitel H, Evans RJ. A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosis. Curr Med Res Opin 22: 495-500, 2006.